Medicine
Clindamycin 150 mg capsule
Clindamycin 150 mg capsule is a generic prescription medicine for oral use, made by 22 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C to 25°C (68°F to 77°F).
Key facts
- Active ingredient (INN)
- Clindamycin
- Brand
- Sold under the generic name
- Strength
- 150 mg
- Dosage form
- Capsule
- Route
- Oral
- Packs
- 100 capsules, 500 capsules, 1000 capsules and 144 more
- Manufacturers
- Micro LabsIndiaSun Pharmaceutical IndustriesIndiaAurobindo PharmaIndiaGlenmark PharmaceuticalsIndiaNuCare Pharmaceuticals,IncA-S Medication SolutionsBrisk PharmaceuticalsChartwell RX22 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at 20°C to 25°C (68°F to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- D10AF01 Clindamycin
- HS code (indicative)
- 3004.20Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 2 February 2001
- Identifiers
- RxCUI 197518, 284215, 309329DailyMed set ID 47f76d99-2024-4531-a527-66c80deeeb37, 535e7e17-d020-4aa6-e063-6294a90ae114, a69260bb-31b5-4f77-e053-2995a90a37e1 +35NDC 71335-2623, 87441-005, 51407-373 +35Application ANDA216957, ANDA065061, ANDA207402 +2
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 22 labelers. The register lists 147 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 capsule in 1 bottle | 65862-185-01 | Aurobindo PharmaIndia | 26 August 2009 |
| 500 capsule in 1 bottle | 65862-185-05 | Aurobindo PharmaIndia | 26 August 2009 |
| 100 capsule in 1 bottle | 68462-143-01 | Glenmark PharmaceuticalsIndia | 10 March 2023 |
| 500 capsule in 1 bottle | 68462-143-05 | Glenmark PharmaceuticalsIndia | 10 March 2023 |
| 100 capsule in 1 bottle | 42571-251-01 | Micro LabsIndia | 7 January 2019 |
| 500 capsule in 1 bottle | 42571-251-05 | Micro LabsIndia | 7 January 2019 |
| 1000 capsule in 1 bottle | 42571-251-10 | Micro LabsIndia | 7 January 2019 |
| 80 blister pack in 1 carton / 10 capsule in 1 blister pack | 42571-251-23 | Micro LabsIndia | 7 January 2019 |
| 100 capsule in 1 bottle | 63304-692-01 | Sun Pharmaceutical IndustriesIndia | 23 March 2001 |
| 10 capsule in 1 bottle | 63304-692-03 | Sun Pharmaceutical IndustriesIndia | 23 March 2001 |
| 500 capsule in 1 bottle | 63304-692-05 | Sun Pharmaceutical IndustriesIndia | 23 March 2001 |
| 100 capsule in 1 carton | 63304-692-77 | Sun Pharmaceutical IndustriesIndia | 23 March 2001 |
| 30 capsule in 1 bottle | 73614-204-03 | Brisk Pharmaceuticals | 10 February 2025 |
| 100 capsule in 1 bottle | 62135-765-01 | Chartwell RX | 12 January 2024 |
| 4 capsule in 1 bottle | 68071-2286-4 | NuCare Pharmaceuticals,Inc | 28 October 2020 |
| 100 capsule in 1 bottle | 68071-2372-1 | NuCare Pharmaceuticals,Inc | 19 March 2021 |
| 21 capsule in 1 bottle | 68071-3582-1 | NuCare Pharmaceuticals,Inc | 25 April 2025 |
| 30 capsule in 1 bottle | 68071-3582-3 | NuCare Pharmaceuticals,Inc | 4 March 2024 |
| 14 capsule in 1 bottle | 68071-3582-4 | NuCare Pharmaceuticals,Inc | 28 January 2025 |
| 60 capsule in 1 bottle | 68071-3582-6 | NuCare Pharmaceuticals,Inc | 8 November 2024 |
| 40 capsule in 1 bottle | 68071-3582-7 | NuCare Pharmaceuticals,Inc | 13 February 2025 |
| 100 capsule in 1 bottle | 68071-3657-1 | NuCare Pharmaceuticals | 20 September 2024 |
| 4 capsule in 1 bottle | 68071-3681-4 | NuCare Pharmaceuticals | 8 October 2024 |
| 6 capsule in 1 bottle | 68071-3681-6 | NuCare Pharmaceuticals | 6 September 2024 |
| 6 capsule in 1 bottle | 68071-3939-6 | NuCare Pharmaceuticals | 30 December 2025 |
| 4 capsule in 1 bottle | 68071-4335-0 | NuCare Pharmaceuticals,Inc | 16 March 2018 |
| 21 capsule in 1 bottle | 68071-4335-1 | NuCare Pharmaceuticals,Inc | 16 March 2018 |
| 20 capsule in 1 bottle | 68071-4335-2 | NuCare Pharmaceuticals,Inc | 16 March 2018 |
| 30 capsule in 1 bottle | 68071-4335-3 | NuCare Pharmaceuticals,Inc | 16 March 2018 |
| 40 capsule in 1 bottle | 68071-4335-4 | NuCare Pharmaceuticals,Inc | 16 March 2018 |
| 60 capsule in 1 bottle | 68071-4335-6 | NuCare Pharmaceuticals,Inc | 16 March 2018 |
| 42 capsule in 1 bottle | 68071-4335-7 | NuCare Pharmaceuticals,Inc | 16 March 2018 |
| 28 capsule in 1 bottle | 68071-4335-8 | NuCare Pharmaceuticals,Inc | 16 March 2018 |
| 21 capsule in 1 bottle | 68071-5189-1 | NuCare Pharmaceuticals,Inc | 2 March 2020 |
| 30 capsule in 1 bottle | 68071-5189-3 | NuCare Pharmaceuticals,Inc | 2 March 2020 |
| 40 capsule in 1 bottle | 68071-5189-4 | NuCare Pharmaceuticals,Inc | 2 March 2020 |
| 28 capsule in 1 bottle | 68071-5189-8 | NuCare Pharmaceuticals,Inc | 2 March 2020 |
| 30 capsule in 1 bottle | 50090-0443-0 | A-S Medication Solutions | 29 June 2016 |
| 15 capsule in 1 bottle | 50090-0443-1 | A-S Medication Solutions | 29 June 2016 |
| 4 capsule in 1 bottle | 50090-0443-3 | A-S Medication Solutions | 29 June 2016 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 22 February 1970 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Clindamycin 150 mg capsule.
Other strengths and forms of Clindamycin
Clinical summary
Clindamycin is a lincosamide antibacterial indicated in the treatment of serious infections caused by susceptible anaerobic bacteria. It is available as capsules, injection and gel for oral, topical and intravenous use. MedsAcross supplies Clindamycin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about ClindamycinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Cleocin Hydrochloride prescribing information (Pharmacia & Upjohn) · U.S. National Library of Medicine, DailyMed
Need Clindamycin 150 mg capsule for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.